BioCentury
ARTICLE | Company News

NovAliX S.A.S., Shionogi deal

April 4, 2011 7:00 AM UTC

NovAliX's Graffinity Pharmaceuticals GmbH subsidiary will use its SPR imaging screening technology to discover small molecule compounds against an undisclosed target from Shionogi. Graffinity will re...